drugset / Trial / NCT01380561

A Metabolite Identification, Mass Balance, and PK Study of [14C]-Asimadoline to Healthy Adult Male Volunteers

NCT01380561 ↗

Phase 1 Completed 6 enrolled Tioga Pharmaceuticals
Non-randomizedSingle-groupOpen-labelBasic science

Summary

This is an open label, single center, metabolite identification, mass balance, and PK study in healthy male volunteers.

Timeline

Start
2011-06
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Asimadoline Small molecule 0.5 mg Oral

Indications

No indication recorded.